Biotechnology
Life After Covid-19: Big Questions on Medical and Bio-Engineering
DAEJEON, South Korea, Sept. 8, 2020 /PRNewswire/ -- On September 9, the Global Strategic Institute at KAIST will delve into innovative future strategies for the medical and bio-engineering sectors that have been disrupted by COVID-19. The forum will live stream via YouTube, KTV, and Naver TV from...
2020-09-08 15:52
2047
Transcenta Holding Announces Appointment of Dr. Charlie Qi as Senior Vice President of Global Clinical Development
SUZHOU, China, Sept.7, 2020 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Charlie Qi as its Senior Vice...
2020-09-07 23:00
1735
PharmAbcine is presenting at the KSMO 2020
DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotechnology company in South Korea, announced today that onSeptember 4th, the company will present the interim data of its ongoing IO combo clinical trials at KSMO 2020. KSMO 2020 is the...
2020-09-02 21:00
2110
PharmAbcine signs a CMO contract with Binex so Binex can produce olinvacimab at its new 5,000L production line
DAEJEON, South Korea, Sept. 2, 2020 /PRNewswire/ -- PharmAbcine (KRX: 208340ks), a biotech company focusing on the development of antibody therapeutics, announcedon August 31 that it had signed a contract manufacturing organization(CMO) agreement with Binex, a leading biologics CDMO(Contract Dev...
2020-09-02 21:00
1984
Clene Nanomedicine, Inc. to go Public through Merger with Tottenham Acquisition I Limited
* Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neur...
2020-09-02 20:00
18877
bitBiome has raised 700 million JPY in Seed financing
TOKYO, Sept. 1, 2020 /PRNewswire/ -- bitBiome, Inc., an emerging leader in microbiome analytics, has raised700 million JPY (approx. $6.6m US) in seed financing from previous and new investors including TheUniversity of Tokyo Edge Capital Partners, Universal Materials Incubator, and otherJapan-ba...
2020-09-02 11:28
1955
Origin Agritech to Present at The LD 500 Virtual Conference
BEIJING,, Aug. 31, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, today announced that it will be presenting at the LD 500 investor conference on Friday, September 4th at8 AM PST / 11 AM EST. Origin's Chairman and Chief Ex...
2020-09-01 01:41
16952
Transcenta Announces First Patient Dosed in Phase I China Trial of Claudin18.2 Targeting Monoclonal Antibody TST001
SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successful...
2020-08-31 23:00
2051
Shandong stages welcoming event for Europe's Fortune 500 companies
JINAN, China, Aug. 30, 2020 /PRNewswire/ -- The "Connecting Shandong with Fortune Global 500" series of events, hosted by the CPC Shandong Provincial Committee and Shandong Provincial People's Government, organized by the Department of Commerce ofShandong Province, and sponsored by FORTUNE CHINA,...
2020-08-31 10:42
2528
New finding - Patient Blood Management delivers cost-effective care
BASEL, Switzerland, Aug. 28, 2020 /PRNewswire/ -- Research recently published
in the journal Anaesthesia
2020-08-28 16:31
1396
GoBroad Healthcare Group Showcases Innovative Hematologic Treatment Capabilities at the China Precision Medicine Forum
BEIJING, Aug. 26, 2020 /PRNewswire/ -- GoBroad Healthcare Group hosted the China Precision Medicine Forum in Hematologic Malignancies & 2nd GoBroad Annual Medical Conference (diagnosis and treatment of diseases of the blood and bone marrow) in early August, covering subjects including diagnosis, ...
2020-08-26 21:00
2173
RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets
WAALWIJK, Netherlands, Aug. 26, 2020 /PRNewswire/ -- RoboPharma announced today the company has been acquired by Capsa Healthcare, a worldwide innovator in healthcare delivery solutions for hospitals, senior care settings, and retail pharmacy providers. Becoming an integral segment within Capsa H...
2020-08-26 08:12
2515
CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells
SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for the first-in-class drug candidate CT041, auto...
2020-08-20 18:32
4487
PharmAbcine announces the execution of a Material Cooperative Research and Development Agreement (MCRADA) with the NIH to evaluate the efficacy of PMC-403 to treat SCLS
DAEJEON, South Korea, Aug. 18, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in whic...
2020-08-18 21:00
8683
Global Cord Blood Corporation to Report First Quarter Fiscal 2021 Financial Results
HONG KONG, Aug. 18, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...
2020-08-18 19:00
3939
China Biologic Reports Financial Results for the Second Quarter of 2020
BEIJING, Aug. 17, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the second quarter of 2020. Second Quart...
2020-08-18 04:30
10022
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...
2020-08-17 20:00
3615
WuXi AppTec Achieved Strong Growth in First-Half of 2020 with China Sites Resuming Full Operations
WuXi AppTec Second-Quarter 2020 Results Revenue Up 29.4% YoY to RMB4,044 Million Net Profit Attributable to Owners of the Company Up 111.0% YoY to RMB1,414 Million Diluted EPS Up 110.3% YoY to RMB0.61 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 43.1% YoY toRMB942 Million...
2020-08-13 16:49
5178
Fapon 2nd COVID-19 Donation, 100 Million Anti-SARS-CoV-2 Fully Human RBD IgM & IgG QC Test Materials
DONGGUAN, China, Aug. 10, 2020 /PRNewswire/ -- Fapon Biotech Inc
2020-08-10 20:00
1935
China Biologic Products to Report Second Quarter 2020 Financial Results
BEIJING, Aug. 10, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that the Company plans to release its second quarter 2020 financial results ...
2020-08-10 20:00
8929
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 334 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 307 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 304 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 302 media titles]
2025-01-21 16:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 288 media titles]
2025-01-20 21:09
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
9917
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
8954
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
8916
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
8753